Clinical trial Recruiting at 1 site Interventional Ages 45 to 65 Women only

Skin changes after biostimulator (Sculptra) treatment seen with non-invasive imaging

Official title: A Single-center, Open-label Study to Characterize Human Skin Changes From Biostimulator Treatments Via Non-invasive Imaging

Run by Galderma R&D · NCT07399028 · Data updated 2026-11-12

We will try Sculptra injections in women aged 45–65 with moderate-to-severe cheek wrinkles to see how their skin changes over three treatments using non-invasive imaging.

More Skin Laxity trials

Quick facts

Study typeInterventional
Ages45 Years to 65 Years
SexWomen only
Enrollment25 (estimated)
SponsorGalderma R&D
Industry-sponsored
Locations1 site (New York, New York)
StatusRecruiting
StartedOctober 21, 2025
Main results expectedSeptember 2026
Study endsSeptember 2026
Registry record updatedFebruary 10, 2026
Trial IDNCT07399028 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 45–65 with moderate-to-severe cheek wrinkles who are willing to receive three Sculptra treatments, follow the provided skincare regimen, and attend imaging and photo visits are ideal candidates.

Probably not a fit

People with known allergy to any ingredient in Sculptra, men, those outside the 45–65 age range, or those unwilling to follow the skincare or visit schedule are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adult female participants with moderate-to-severe cheek wrinkles will receive Sculptra injections planned as three treatments, with standardized photographs and non-invasive imaging taken at each visit. Participants will stop their current facial skincare and use provided cleanser, moisturizer, and sunscreen for the study duration to reduce variability. Imaging and photo documentation will be used to characterize changes in skin volume, texture, and laxity over time. The single-site study is sponsored by Galderma R&D and conducted at a clinic in New York City.

Why it matters

Potential benefit: If successful, the approach could improve understanding of how Sculptra changes cheek volume and appearance and help guide better treatment planning.

How similar studies have gone: Previous studies have shown Sculptra can restore facial volume and reduce wrinkles, although using detailed non-invasive imaging to characterize these changes is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult subjects aged 45-65 years old
* Females only
* Subject with moderate-to-severe cheek wrinkles on the GCWS
* Subject with intent to undergo correction of cheek wrinkles on both sides of the face
* Subject who in the opinion of the Investigator would need 3 treatments for optimal clinical outcomes
* Subject willing to be photographed at each visit.
* Subjects willing to stop using current facial skincare products for the duration of the study.
* Subject willing to replace the current facial skincare products with the provided facial skincare products, including cleanser, moisturizer and sunscreen, until study completion.
* Ability to read, understand and give consent for participation in the study.
* Agreement to adhere to the procedures and requirements of the study and to report to the site on the day(s) and at the time(s) scheduled for the assessments.

Exclusion Criteria:

* Subjects with a history of allergy or hypersensitivity to any ingredient of the treatment products.
* Previous tissue-augmenting therapy, contouring, or revitalization treatment in the face, except lips.
* Previous treatment/procedure in the face in the previous 6 months that, in the Investigator's opinion, would interfere with the study injections and/or study assessments or exposed the study subject to undue risk by study participation, or planning to undergo any of these procedures affecting the treatment area at any time during the study.
* Subjects with any medical condition that, in the opinion of the Investigator, would make the subject unsuitable for inclusion.

Where it's running

  • Luxurgery
    New York, New York, United States
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.